Emergent BioSolutions Inc.·4

Mar 3, 4:16 PM ET

Glessner Coleen 4

4 · Emergent BioSolutions Inc. · Filed Mar 3, 2026

Insider Transaction Report

Form 4
Period: 2026-03-01
Glessner Coleen
EVP, Quality & Ethics, and CPL
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-03-01$8.15/sh313$2,551112,307 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units.
Signature
/s/ Richard S. Lindahl, Attorney-in-fact|2026-03-03

Documents

1 file
  • 4
    wk-form4_1772572600.xmlPrimary

    FORM 4